Search Results 541-550 of 2967 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com
About this study. The overall goal of this proposal is to determine the effects of acute hyperglycemia and its modulation by Glucagon-like Peptide-1 (GLP-1) ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
Dr. Ackerman's Sudden Death Genomics Lab leverages the expertise of other scientists on sudden death and cardiac conditions at Mayo Clinic and at other ...
Drugs used in chemotherapy, such as carmustine, etoposide phosphate, cytarabine, and melphalan (BEAM), work in different ways to stop the growth of cancer cells ...
Jannetto PJ, Langman LJ. High-throughput online solid-phase extraction tandem mass spectrometry: Is it right for your clinical laboratory? Clin Biochem. 2016 ...
Lezlie Halbach Andersen, M.D., is a pediatric hospitalist and pediatric hospice and palliative care provider. As a pediatric hospitalist, she cares for ...
Response-based treatment may be effective in treating acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome while reducing ...
Dr. Athreya's Health Engineering and Analytics Lab at Mayo Clinic studies multi-omics for precision medicine and digital health for psychiatry and mental ...
2017. Fellow - Cerebrovascular neurologyStrong Memorial Hospital, University of Rochester Medical Center · 2016. ResidentNeurology, Programs in Rochester, Mayo ...
This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.